Antagen Pharmaceuticals Inc

Opexa Therapeutics is a biotechnology company that specializes in the development of patient-specific cellular therapies for the treatment of autoimmune diseases, such as multiple sclerosis and diabetes. It offers Tovaxin, which is a vaccine for early relapsing multiple sclerosis. The company also offers an adult stem cell program that enables the production of multipotent cells generated from patients white blood cells and provides means to differentiate these stem cells into other tissue types. Opexa Therapeutics offers solutions that minimize the threat of treatment rejection. It operates clinical advisory boards for multiple sclerosis and diabetes that take care of the supervision of related procedures. The company provides products to target individual s disease progression and modification.

Paratek Pharmaceuticals, based in Boston, MA, is a biopharmaceutical company dedicated to addressing the critical global public health issue of antimicrobial resistance (AMR). With a focus on developing innovative treatment options for complex medical issues, Paratek is committed to combatting AMR through responsible antibiotic use, improved surveillance, and research into new antibiotics. Grounded in a mission to save lives, Paratek's FDA-approved tetracycline-class antibiotic, NUZYRA, targets adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria. The company's disciplined team of experts is driven to provide new technologies that can defeat superbugs and contribute to a vibrant marketplace that recognizes the life-saving value of novel antibiotics.Generated from the website

Steraloids, located in Newport, RI, is a leading provider of steroid research standards and starting materials, boasting an extensive catalogue of over 2,700 products, including estrogens, bile acids, and hormones. With more than 60 years of experience, the company serves a diverse clientele, including research institutions, pharmaceutical companies, and law enforcement agencies, while offering custom syntheses to meet specific research needs. Renowned for its high-quality standards, Steraloids is licensed by the DEA in the U.S.A. and specializes in the synthesis of both synthetic and endogenous steroids for research testing and synthesis. Their commitment to individualized service ensures that all orders, from bulk quantities to custom requests, are tailored to the unique requirements of their clients. Generated from the website